| Geetha Palaniappan, MD | |
|
611 Fenwick Dr, Papillion, NE 68046-5706 | |
| (402) 593-3141 | |
| (402) 593-3145 |
| Full Name | Geetha Palaniappan |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 30 Years |
| Location | 611 Fenwick Dr, Papillion, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376638668 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2006011987 (Missouri) | Secondary |
| 207R00000X | Internal Medicine | 23038 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Methodist Hospital | Omaha, NE | Hospital |
| Chi Health Midlands | Papillion, NE | Hospital |
| Chi Health Bergan Mercy | Omaha, NE | Hospital |
| Chi Health Lakeside | Omaha, NE | Hospital |
| Bellevue Medical Center | Bellevue, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nebraska Cancer Specialists | 8426030024 | 44 |
News Archive
A combination of reduced-dose radiotherapy using intensity-modulated radiotherapy (IMRT) combined with concurrent cisplatin met the threshold for disease control and quality of life compared to the standard of care for good-risk patients with HPV-associated oropharyngeal squamous cell carcinoma on the NRG Oncology clinical trial NRG-HN002.
Also in Medicaid news, Washington state begins new program that limits emergency department visits for Medicaid enrolless. Oregon also reports gains in efforts to get children coverage.
A top specialist in occupational health has hit out at those who pour scorn on her industry and like to refer to it as 'Elf and Safety', despite the fact that 180 people a year die in workplace accidents and more than 246,000 are injured.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
› Verified 7 days ago
| Entity Name | Oncology Hematology West, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932178530 PECOS PAC ID: 8426030024 Enrollment ID: O20040607000705 |
News Archive
A combination of reduced-dose radiotherapy using intensity-modulated radiotherapy (IMRT) combined with concurrent cisplatin met the threshold for disease control and quality of life compared to the standard of care for good-risk patients with HPV-associated oropharyngeal squamous cell carcinoma on the NRG Oncology clinical trial NRG-HN002.
Also in Medicaid news, Washington state begins new program that limits emergency department visits for Medicaid enrolless. Oregon also reports gains in efforts to get children coverage.
A top specialist in occupational health has hit out at those who pour scorn on her industry and like to refer to it as 'Elf and Safety', despite the fact that 180 people a year die in workplace accidents and more than 246,000 are injured.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Geetha Palaniappan, MD 611 Fenwick Dr, Papillion, NE 68046-5706 Ph: (402) 593-3141 | Geetha Palaniappan, MD 611 Fenwick Dr, Papillion, NE 68046-5706 Ph: (402) 593-3141 |
News Archive
A combination of reduced-dose radiotherapy using intensity-modulated radiotherapy (IMRT) combined with concurrent cisplatin met the threshold for disease control and quality of life compared to the standard of care for good-risk patients with HPV-associated oropharyngeal squamous cell carcinoma on the NRG Oncology clinical trial NRG-HN002.
Also in Medicaid news, Washington state begins new program that limits emergency department visits for Medicaid enrolless. Oregon also reports gains in efforts to get children coverage.
A top specialist in occupational health has hit out at those who pour scorn on her industry and like to refer to it as 'Elf and Safety', despite the fact that 180 people a year die in workplace accidents and more than 246,000 are injured.
BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
› Verified 7 days ago
Mary Dankof, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11111 S 84th St, Papillion, NE 68046 Phone: 402-593-3131 Fax: 402-593-3117 | |
Sean Kelly, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 Laura Cir, Papillion, NE 68046 Phone: 402-250-4804 | |
Dr. Timothy K. Huyck, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 Fenwick Dr, Papillion, NE 68046 Phone: 402-593-3141 | |
Fredrick Schwartz, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 11109 S 84th St, Suite 5800, Papillion, NE 68046 Phone: 402-827-4900 |